Quorum Review IRB Launches Program for Phase I Clinical Trials
Quorum Review IRB is introducing a comprehensive program that supports the needs of Phase I Healthy patients.
Quorum Review IRB is introducing a comprehensive program that supports the needs of Phase I Healthy patients. With this new Phase I Program, a study can be ready to enroll participants within a few days of submitting their materials. Quorum’s new program also provides alternatives in the review of recruitment materials. It can also conditionally approve recruitment materials before the protocol review is finalized, it allows a proactive plan for deployment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
